FIELD: medicine.
SUBSTANCE: present invention relates to used in medicine compound of formula I 
where T denotes -C*H(R1)-P-Q; R1 denotes C1-C6alkyl optionally substituted OH or C1-C6alkoxy; P denotes a 5- or 6-member heteroaryl containing atoms of nitrogen, oxygen and sulphur; Q denotes a 5- or 6-member heteroaryl containing atoms of nitrogen, oxygen and sulphur; optionally substituted amino groups or hydroxy groups; P is connected to Q through carbon-carbon bond; and R3 denotes a hydrogen atom.
EFFECT: there are presented new effective antibacterial compounds obtained new effective methods to create a based pharmaceutical compositions and treatment of bacterial infections.
32 cl, 4 tbl, 65 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED ARYLTHIOALKYLTHIOPYRIDINES, METHOD OF THEIR SYNTHESIS, DRUG BASED ON THEREOF AND METHOD OF DRUG PREPARING | 1994 |
|
RU2154062C2 |
| SUBSTITUTED ARYLALKYLTHIOALKYLTHIOPYRIDINES USED FOR CONTROL OF BACTERIUM HELICOBACTER | 1995 |
|
RU2139286C1 |
| AZAINDOL DERIVATIVES AS FACTOR Xa INHIBITORS | 2004 |
|
RU2330853C2 |
| POLYCYCLIC AGENTS FOR TREATING RESPIRATORY SYNCYTIAL VIRAL INFECTIONS | 2004 |
|
RU2422444C2 |
| IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2678305C1 |
| THIOPYRIDINES USED FOR CONTROL OF HELICOBACTER BACTERIA | 1995 |
|
RU2142459C1 |
| PYRIDINO[1,2-A]PYRIMIDONE ANALOGUE USED AS AN MTOR/PI3K INHIBITOR | 2015 |
|
RU2658912C1 |
| 2-(PHENYL OR PYRID-3-YL)AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF LEUCINE-RICH REPEATING KINASE 2 (LRRK2) FOR TREATMENT OF PARKINSON'S DISEASE | 2012 |
|
RU2647849C2 |
| ARYLCYCLOPROPYLAMINE BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE | 2011 |
|
RU2611437C2 |
| TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2696270C1 |
